Particularly, the reduction of GLP-1 release over time has been an observed feature of T2DM development, as GLP-1 reduces glucagon secretion and hepatic gluconeogenesis while promoting insulin secretion, thereby effectively minimizing hyperglycemia [106]
Important red flags that require immediate medical attention include: Severe, persistent abdominal pain (possibly radiating to the back) with or without vomiting, which may suggest acute pancreatitis Right upper quadrant pain, fever, or yellowing of the skin/eyes, which could indicate gallbladder disease Reduced urine output or marked dehydration from persistent gastrointestinal symptoms Sudden changes in vision, particularly in those with diabetic retinopathy Cardiovascular symptoms such as palpitations, chest discomfort, or lightheadedness should prompt immediate medical review
Honestly, one isn't better than the other
Personalized Energy Prediction With Genetic Testing The PlexusDx Precision Peptide Genetic Test analyzes GIPR (rs1800437) and FTO (rs9939609) variants that relate to GLP-1 and related signaling pathways
GLP-1-based therapy for obesity